Seres Therapeutics Inc (MCRB) support and resistance · rev $1.1M
Seres Therapeutics Inc (MCRB) is a biotechnology company listed on US.
This page maps Seres Therapeutics Inc (MCRB) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported MCRB revenue for 2026-06-30 was $1.1M. Net income was -$15.3M. MCRB currently screens at market cap $109.8M.
MCRB currently screens at market cap $109.8M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new MCRB 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the MCRB quote page for the session range and the stock page for the full model.
Not investment advice.